vimarsana.com

Page 52 - Dexcom Real Time News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Insider Selling: DexCom, Inc (NASDAQ:DXCM) Director Sells $43,989 33 in Stock

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) Director Steven Robert Pacelli sold 411 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $107.03, for a total value of $43,989.33. Following the completion of the sale, the director now directly owns 126,008 shares of […]

Insider Selling: DexCom, Inc (NASDAQ:DXCM) CFO Sells $192,476 72 in Stock

Insider Selling: DexCom, Inc (NASDAQ:DXCM) CFO Sells $192,476 72 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

DexCom, Inc (NASDAQ:DXCM) Director Sells $43,989 33 in Stock

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) Director Steven Robert Pacelli sold 411 shares of the business’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $107.03, for a total transaction of $43,989.33. Following the completion of the transaction, the director now owns 126,008 shares in the […]

Robert W Baird Trims DexCom (NASDAQ:DXCM) Target Price to $130 00

DexCom (NASDAQ:DXCM – Free Report) had its target price lowered by Robert W. Baird from $153.00 to $130.00 in a research report released on Monday morning, MarketBeat reports. The brokerage currently has an outperform rating on the medical device company’s stock. A number of other research analysts have also weighed in on the stock. UBS […]

Robert W Baird Lowers DexCom (NASDAQ:DXCM) Price Target to $130 00

DexCom (NASDAQ:DXCM – Free Report) had its target price reduced by Robert W. Baird from $153.00 to $130.00 in a report released on Monday morning, Marketbeat reports. They currently have an outperform rating on the medical device company’s stock. DXCM has been the topic of several other research reports. UBS Group boosted their target price […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.